Applied Biologics, a biopharmaceutical company advancing novel biologic therapies for serious diseases with significant unmet medical needs, today announced the initiation of a multi-center ...
The study assessed the impact of Control-IQ technology—an automated insulin delivery (AID) therapy—on the HEDIS-recommended ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results